Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Form 8.3 - [FFastFill PLC]

12 Mar 2013 16:56

RNS Number : 8490Z
Maven Income and Growth VCT 5 PLC
12 March 2013
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Maven Income and Growth VCT 5 PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FFastfill Plc Ordinary 1p Shares

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

11 March 2013

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,082,318

0.22

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,082,318

0.22

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

11 March 2013

Contact name:

Graeme Cullen

Telephone number:

0141 206 0110

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETSFIFMEFDSEID
Date   Source Headline
12th Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
27th Feb 20184:02 pmRNSTransaction in Own Shares
13th Feb 20183:39 pmRNSTransaction in Own Shares
25th Jan 20185:01 pmRNSTransaction in Own Shares
23rd Jan 20185:23 pmRNSTransaction in Own Shares
17th Jan 20182:46 pmRNSNet Asset Value(s)
3rd Jan 20182:00 pmRNSForm 8.3 - Plant Impact PLC
30th Nov 20174:42 pmRNSTransaction in Own Shares
29th Nov 20174:40 pmRNSTransaction in Own Shares
25th Oct 20173:05 pmRNSDividend Declaration
29th Sep 20174:01 pmRNSNet Asset Value(s)
23rd Aug 20174:50 pmRNSTransaction in Own Shares
23rd Aug 20177:00 amRNSTransaction in Own Shares
22nd Aug 20177:00 amRNSHalf-year Report
10th Aug 20174:11 pmRNSNet Asset Value and Interim Dividend
31st May 20174:58 pmRNSTransaction in Own Shares
16th May 20173:57 pmRNSTransaction in Own Shares
11th May 20172:03 pmRNSTransaction in Own Shares
25th Apr 20172:14 pmRNSResult of AGM
25th Apr 20172:12 pmRNSNet Asset Value and Proposed Final Dividend
6th Mar 20176:12 pmRNSAnnual Financial Report
6th Mar 20176:04 pmRNSCorrective Statement re Proposed Final Dividend
25th Jan 20179:56 amRNSNet Asset Value and Proposed Final Dividend
14th Nov 201610:06 amRNSForm 8.3 - MBL Group PLC
20th Oct 20163:18 pmRNSTransaction in Own Shares
6th Oct 201612:31 pmRNSNet Asset Value(s)
19th Sep 20164:24 pmRNSChange of Auditor
27th Jul 201611:04 amRNSHalf-year Report
15th Jul 201612:06 pmRNSUnaudited NAV and Interim Dividend
19th Apr 20163:48 pmRNSNet Asset Value(s)
19th Apr 20163:14 pmRNSResult of AGM
17th Mar 20167:00 amRNSAnnual Financial Report
15th Feb 20163:34 pmRNSTransaction in Own Shares
10th Feb 20163:43 pmRNSForm 8.3 - Tangent Communications PLC
9th Feb 20164:42 pmRNSTransaction in Own Shares
25th Jan 20161:49 pmRNSNet Asset Value(s)
18th Dec 20154:20 pmRNSDirector Declaration
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
13th Oct 20152:28 pmRNSTransaction in Own Shares
9th Oct 20159:58 amRNSNet Asset Value(s)
28th Aug 20152:49 pmRNSTransaction in Own Shares
27th Aug 20154:14 pmRNSTransaction in Own Shares
24th Aug 20153:46 pmRNSStatement re Dividend Investment Scheme
24th Jul 20153:12 pmRNSStatement re Related Party Transaction
24th Jul 20153:05 pmRNSHalf Yearly Report
23rd Jul 20154:25 pmRNSStatement re NAV and Interim Dividend
15th Jun 20155:28 pmRNSDirector/PDMR Shareholding
12th Jun 201510:06 amRNSIssue of Equity
5th Jun 20153:19 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.